The development and validation of a column chart for predicting the regression risk of CIN2
Authors:
Open Access
- 27 March 2025
- journal article
- research article
- Published by Springer Nature in Discover Oncology
- Vol. 16 (1) , 1-11
Abstract
Background A predictive nomogram model was established for the prognosis of cervical intraepithelial neoplasia 2 (CIN2). Methods This study was based on the research data of CIN2 obtained from the Shanxi CIN cohort study from 2019 to 2022. We conducted a cross-sectional analysis of 512 female patients with CIN2. Subsequently, the least absolute shrinkage and selection operator (LASSO) regression, along with univariate and multivariate regression analyses, were conducted to identify five risk factors associated with CIN2 prognosis. These factors include age at first sexual activity, ThinPrep cytologic test (TCT) results, Human papillomavirus (HPV) infection type, lesion area detected by colposcopy, and acetowhitening thickness. A predictive model was constructed employing R software. Receiver operating characteristic (ROC) curve and resampling methods were employed to evaluate the predictive model in terms of accuracy and calibration. Decision curve analysis (DCA) was performed to assess its clinical application value. Results Women with CIN2 (n = 512) aged 19–65 were included in the study; after 6 months of follow-up, 185 showed lesion regression, and 336 showed lesion persistence or progression. The factors for the predictive model included age of sexual activity (P = 0.005), multiple sexual partners (P = 0.076), TCT results (P < 0.0001), HPV infection (P = 0.0025), lesion area (P < 0.0001), and the thickness of acetic acid stain (P < 0.0001). Subsequent ROC curve analysis showed the respective sensitivity and specificity of the predictive model to be 0.827 and 0.708. Finally, DCA, used to assess the predictive value of the 5-factor CIN2 regression predictive model, was higher than the combined predictive model of HPV and TCT. Conclusion The study could successfully establish a model for predicting the pathological regression status of CIN2 patients.Keywords
Funding Information
- the Special Public Welfare Industry Research of National Health and Family Planning Commission of China (201402010)
- The National Natural Science Foundation of China (81972452)
- the Shanxi Cervical Disease Clinical Medical Research Center (201905K111005)
- the Natural Science Foundation of Shanxi Province (20210302124591)
This publication has 39 references indexed in Scilit:
- The Positive Predictive Value of High-Grade Squamous Intraepithelial Lesion on Cytology for the Histological Diagnosis of Cervical Intraepithelial Neoplasia 2 or Higher: A Systematic ReviewActa Cytologica, 2019
- HPV Vaccine: Updates and HighlightsActa Cytologica, 2019
- Justifying conservative management of CIN2 in women younger than 25 years - A population-based studyGynecologic Oncology, 2019
- Value of HPV 16/18 Genotyping and p16/Ki-67 Dual Staining to Predict Progression to HSIL/CIN2+ in Negative Cytologies From a Colposcopy Referral PopulationAmerican Journal of Clinical Pathology, 2018
- Outcomes of Conservative Management of High Grade Squamous Intraepithelial Lesions in Young WomenJournal of Lower Genital Tract Disease, 2018
- Clinical course of untreated cervical intraepithelial neoplasia grade 2 under active surveillance: systematic review and meta-analysisBMJ, 2018
- Conservative management of CIN2: National Audit of British Society for Colposcopy and Cervical Pathology members’ opinionJournal of Obstetrics and Gynaecology, 2017
- Significance of HPV-58 Infection in Women Who Are HPV-Positive, Cytology-Negative and Living in a Country with a High Prevalence of HPV-58 InfectionPLOS ONE, 2013
- Unique variants of human papillomavirus genotypes 52 and 58 and risk of cervical neoplasiaInternational Journal of Cancer, 2010
- Predictors of human papillomavirus persistence among women with equivocal or mildly abnormal cytologyInternational Journal of Cancer, 2009